Cargando…
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
PURPOSE: Transdermal fentanyl is effective for the treatment of moderate to severe cancer-related pain but is unsuitable for fast titration. In this setting, continuous subcutaneous fentanyl may be used. As data on the pharmacokinetics of continuous subcutaneous fentanyl are lacking, we studied the...
Autores principales: | Oosten, Astrid W., Abrantes, João A., Jönsson, Siv, de Bruijn, Peter, Kuip, Evelien J. M., Falcão, Amílcar, van der Rijt, Carin C. D., Mathijssen, Ron H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792338/ https://www.ncbi.nlm.nih.gov/pubmed/26762381 http://dx.doi.org/10.1007/s00228-015-2005-x |
Ejemplares similares
-
Population pharmacokinetics of cefotaxime in intensive care patients
por: Swartling, Maria, et al.
Publicado: (2021) -
In silico comparison of pharmacokinetic properties of three extended half-life factor IX concentrates
por: Preijers, Tim, et al.
Publicado: (2021) -
Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment
por: Wu, Wanhong, et al.
Publicado: (2021) -
Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib
por: Small, David S., et al.
Publicado: (2016) -
Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)